E2F1 and glioma: In both TCGA and Gravendeel cohorts, gliomas with a STAT3high gene signature (associated with inferior glioma patient survival and GBM [39]) significantly expressed higher E2F1 and H2AZ2 levels than tumors with a STAT3low gene signature (Fig. 7G, H).